Venous outcomes at 1 year after using the femoral vein as a conduit for passage of percutaneous femoropopliteal bypass
- 1 September 2021
- journal article
- conference paper
- Published by Elsevier in Journal of Vascular Surgery: Venous and Lymphatic Disorders
- Vol. 9 (5) , 1266-1272.e3
Abstract
No abstract availableKeywords
Funding Information
- Cleveland Clinic
This publication has 12 references indexed in Scilit:
- One-year results from the DETOUR I trial of the PQ Bypass DETOUR System for percutaneous femoropopliteal bypassJournal of Vascular Surgery, 2020
- Drug-Eluting Stent Versus Drug-Coated Balloon Revascularization in Patients With Femoropopliteal Arterial DiseaseJACC, 2019
- Thrombosis in cancer patients: etiology, incidence, and managementCardiovascular Diagnosis and Therapy, 2017
- Twelve-Month Results From the MAJESTIC Trial of the Eluvia Paclitaxel-Eluting Stent for Treatment of Obstructive Femoropopliteal DiseaseJournal of Endovascular Therapy, 2016
- IP209. Perioperative Complications Increase Risk of Deep Vein Thrombosis in Patients Undergoing Infrainguinal BypassJournal of Vascular Surgery, 2016
- Covered vs Uncovered Stents for Aortoiliac and Femoropopliteal Arterial DiseaseJournal of Endovascular Therapy, 2016
- Predicting of Venous Thromboembolism for Patients Undergoing Gynecological SurgeryMedicine, 2015
- Neoaortoiliac System (NAIS) Procedure for the Treatment of the Infected Aortic GraftSeminars in Vascular Surgery, 2011
- Venous thromboembolism and prognosis in cancerThrombosis Research, 2010
- Incidence and mortality of venous thrombosis: a population‐based studyJournal of Thrombosis and Haemostasis, 2007